Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,279,497
-$6,916,779 QoQ
Shares Held
1,929,953
+13.8% QoQ
Ownership
0.554%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. NUVB ranks #150 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,279,497 | 1,929,953 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,196,276 | 1,696,013 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $4,449,678 | 1,202,616 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,882,184 | 1,478,044 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,803,335 | 1,024,623 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $5,399,197 | 2,029,774 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,032,348 | 1,324,170 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,327,356 | 1,139,506 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,148,966 | 1,139,826 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,199,102 | 794,108 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $552,819 | 412,553 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $902,693 | 501,497 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $660,913 | 398,141 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $463,007 | 241,150 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $1,219,336 | 544,347 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $469,948 | 145,046 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $3,768,499 | 716,445 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,248,208 | 146,848 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $544,443 | 54,773 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $1,501,972 | 161,329 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,302,061 | 220,293 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||